Citation Impact
Citing Papers
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
The clinical symptoms of Parkinson's disease
2016 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
2012 Standout
Use of a Refined Drug Tracer Algorithm to Estimate Prevalence and Incidence of Parkinson's Disease in a Large Israeli Population
2011
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Impact of different exercise training modalities on the coronary collateral circulation and plaque composition in patients with significant coronary artery disease (EXCITE trial): study protocol for a randomized controlled trial
2012
Computed Fractional Flow Reserve (FFTCT) Derived from Coronary CT Angiography
2013
Parkinson disease
2017 Standout
Size and burden of mental disorders in Europe—a critical review and appraisal of 27 studies
2005
Parkinson's disease
2021 Standout
Mechanism and medical implications of mammalian autophagy
2018 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Trends in Parkinson’s disease related mortality in England and Wales, 1993–2006
2009
Neuroimaging in Parkinson disease: from research setting to clinical practice
2014
Geographic and Ethnic Variation in Parkinson Disease: A Population-Based Study of US Medicare Beneficiaries
2010
Epidemiology of psychosis in Parkinson's disease
2009
Blood profile holds clues to role of infection in a premonitory state for idiopathic parkinsonism and of gastrointestinal infection in established disease
2009
Parkinson's disease: clinical features and diagnosis
2008 Standout
Ageing as a risk factor for neurodegenerative disease
2019 Standout
Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson's disease: a double-blind, randomised controlled trial
2019
The changing landscape of atherosclerosis
2021 StandoutNature
Novel investigational adenosine A2Areceptor antagonists for Parkinson's disease
2009
Overdependence on degraded gist memory in Alzheimer's disease.
2006 Standout
International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors—An Update
2011 Standout
Dementia Risk in Parkinson Disease
2011
Parkinson's disease
2009 Standout
Are delayed‐start design trials to show neuroprotection in Parkinson's disease fundamentally flawed?
2008
Epidemiology of Parkinson’s disease
2017 Standout
Emerging drugs for autonomic dysfunction in Parkinson's disease
2013
Chronic non-specific low back pain – sub-groups or a single mechanism?
2008
Coronary Microvascular Disease Pathogenic Mechanisms and Therapeutic Options
2018
Late-stage Parkinson disease
2012
The SYNTAX Score and SYNTAX-Based Clinical Risk Scores
2011
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Parkinson's disease
2015 Standout
(Poly)phenols protect from α-synuclein toxicity by reducing oxidative stress and promoting autophagy
2014
Pharmacotherapy of Parkinson’s disease in Germany
2005
Prevalence of Parkinson's disease and other types of parkinsonism in the Aeolian Archipelago, Sicily
2008
Diagnostic Accuracy of Fractional Flow Reserve From Anatomic CT Angiography
2012
Non-Fibroatheroma Lesion Phenotype and Long-Term Clinical Outcomes
2013
Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial
2013 Standout
Missing pieces in the Parkinson's disease puzzle
2010
Cognitive impairment in 873 patients with idiopathic Parkinson's disease
2008
Functional assessment of coronary stenoses: can we live without it?
2012
Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines
2012 Standout
The epidemiology of Parkinson's disease: risk factors and prevention
2016 Standout
Parkinsonism in a population of northern Tanzania: a community-based door-to-door study in combination with a prospective hospital-based evaluation
2009
Fractional Flow Reserve in Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction
2011
Non-motor features of Parkinson disease
2017 Standout
The size and burden of mental disorders and other disorders of the brain in Europe 2010
2011 Standout
Changes in Prevalence and Incidence of Parkinson’s Disease in Japan during a Quarter of a Century
2009
Visual symptoms in Parkinson's disease and Parkinson's disease dementia
2011
Outcomes of Anatomical versus Functional Testing for Coronary Artery Disease
2015
Exercise-based cardiac rehabilitation for coronary heart disease
2011 Standout
Systematic review of levodopa dose equivalency reporting in Parkinson's disease
2010 Standout
Non-specific low back pain
2011 Standout
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
The global prevalence of common mental disorders: a systematic review and meta-analysis 1980–2013
2014 Standout
Traditional usages, botany, phytochemistry, pharmacology and toxicology of Polygonum multiflorum Thunb.: A review
2014 Standout
What is the impact of mental health-related stigma on help-seeking? A systematic review of quantitative and qualitative studies
2014 Standout
Key challenges for delivering clinical impact with artificial intelligence
2019 Standout
Incidence and prevalence of Parkinson’s disease in Buenos Aires City, Argentina
2012
Is cardiac function impaired in premotor Parkinson's disease? A retrospective cohort study
2013
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration
2016 Standout
Dementia and survival in Parkinson disease
2008
Pharmacological interventions for somatoform disorders in adults
2014 Standout
Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease
2009 Standout
Motor and Cognitive Advantages Persist 12 Months After Exenatide Exposure in Parkinson’s Disease
2014
Predicting diagnosis of Parkinson's disease: A risk algorithm based on primary care presentations
2019
2014 ACC/AHA/AATS/PCNA/SCAI/STS Focused Update of the Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease
2014
Mechanisms of Plaque Formation and Rupture
2014 Standout
Multi-State Models for Panel Data: ThemsmPackage forR
2011 Standout
Exploring the relationship between essential tremor and Parkinson's disease
2006
Epidemiology ofDSM-5Alcohol Use Disorder
2015 Standout
Adult Hippocampal Neurogenesis in Parkinson’s Disease: Impact on Neuronal Survival and Plasticity
2014
Effectiveness of multidisciplinary care for Parkinson's disease: A randomized, controlled trial
2012
Guidelines for Adult Stroke Rehabilitation and Recovery
2016 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
2014 ACC/AHA/AATS/PCNA/SCAI/STS Focused Update of the Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease
2014
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
A review of disease progression models of Parkinson's disease and applications in clinical trials
2016
The MoCA
2010 Standout
Heart Disease Identification Method Using Machine Learning Classification in E-Healthcare
2020 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
The prevalence of Parkinson's disease: A systematic review and meta‐analysis
2014 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Nonlinear speech analysis algorithms mapped to a standard metric achieve clinically useful quantification of average Parkinson's disease symptom severity
2010
Oxidative Stress: A Key Modulator in Neurodegenerative Diseases
2019 Standout
Works of Bernhard Bornschein being referenced
Rate of clinical progression in Parkinson's disease. A prospective study
2007
Fractional Flow Reserve Versus Angiography for Guiding Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease
2010
Dopamine transporter imaging and SPECT in diagnostic work-up of Parkinson's disease: A decision-analytic approach
2003
Cost of Illness and its Predictors for Parkinson??s Disease in Germany
2005
Prevalence and incidence of Parkinson's disease in Europe
2005
Economic Evaluation of Fractional Flow Reserve–Guided Percutaneous Coronary Intervention in Patients With Multivessel Disease
2010